{"transactions":[{"id":4619536,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2026-09-16T20:35:39.000Z","date":"2026-09-15","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on January 27, 2022 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":63.68,"expiration_date":"2032-01-27","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-26-393147","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526393147/ownership.xml","form_type":"4"}},{"id":4619535,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2026-09-16T20:35:39.000Z","date":"2026-09-15","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on January 26, 2024 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":53.75,"expiration_date":"2034-01-26","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-26-393147","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526393147/ownership.xml","form_type":"4"}},{"id":4619534,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-16T20:35:39.000Z","date":"2026-09-15","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":74.5834,"value":2237502.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.33 to $74.96, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-393147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526393147/ownership.xml","form_type":"4"}},{"id":4619533,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-16T20:35:39.000Z","date":"2026-09-15","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":63.68,"value":955200.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001193125-26-393147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526393147/ownership.xml","form_type":"4"}},{"id":4619532,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-16T20:35:39.000Z","date":"2026-09-15","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":53.75,"value":806250.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001193125-26-393147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526393147/ownership.xml","form_type":"4"}},{"id":685310,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-17T20:45:05.000Z","date":"2026-08-17","kind":"gift","planned":false,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Tobin 2024 Family Trust"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-354202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000119312526354202/ownership.xml","form_type":"4"}},{"id":765628,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T20:15:08.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":2922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 2,922 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":6981,"source":{"system":"sec-edgar","filing":"0001193125-26-236906","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000119312526236906/ownership.xml","form_type":"4"}},{"id":932088,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2026-01-23T21:53:55.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 21, 2026, and will vest on January 1, 2027."}],"balance_after":15000,"derivative":{"exercise_price":94.15,"expiration_date":"2036-01-21","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-26-021205","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526021205/ownership.xml","form_type":"4"}},{"id":1134994,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-23T22:47:12.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":2134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 2,134 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":4059,"source":{"system":"sec-edgar","filing":"0000950170-25-077221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017025077221/ownership.xml","form_type":"4"}},{"id":1145037,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-16T20:30:42.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% on the earlier of (i) the day before the Issuer's next annual meeting, (ii) May 14, 2026 and (iii) upon a Change in Control as defined in the 2020 Incentive Award Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% on the earlier of (i) the day before the Issuer's next annual meeting, (ii) May 14, 2026 and (iii) upon a Change in Control as defined in the 2020 Incentive Award Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% on the earlier of (i) the day before the Issuer's next annual meeting, (ii) May 14, 2026 and (iii) upon a Change in Control as defined in the 2020 Incentive Award Plan."}],"balance_after":32000,"derivative":{"underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0000950170-25-073609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017025073609/ownership.xml","form_type":"4"}},{"id":1188730,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2025-03-28T22:41:21.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 23, 2025, and will vest on January 1, 2026."}],"balance_after":15000,"derivative":{"exercise_price":92.42,"expiration_date":"2035-01-23","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-25-047024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017025047024/ownership.xml","form_type":"4"}},{"id":1404859,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T23:27:27.000Z","date":"2024-09-13","kind":"gift","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Tobin 2024 Family Trust"},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0000950170-24-107493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024107493/ownership.xml","form_type":"4"}},{"id":1404858,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T23:27:27.000Z","date":"2024-09-13","kind":"gift","planned":false,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"balance_after":155146,"source":{"system":"sec-edgar","filing":"0000950170-24-107493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024107493/ownership.xml","form_type":"4"}},{"id":1436776,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-09T20:30:14.000Z","date":"2024-08-08","kind":"sale","planned":false,"acquired":false,"shares":7336,"price":159.96,"value":1173466.56,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $159.77 to $160.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":173146,"source":{"system":"sec-edgar","filing":"0000950170-24-094806","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024094806/ownership.xml","form_type":"4"}},{"id":1436775,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-09T20:30:14.000Z","date":"2024-08-08","kind":"sale","planned":false,"acquired":false,"shares":12664,"price":158.96,"value":2013069.44,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $158.75 to $159.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":180482,"source":{"system":"sec-edgar","filing":"0000950170-24-094806","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024094806/ownership.xml","form_type":"4"}},{"id":1478747,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-14T20:10:08.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) and (ii) the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case, subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0.31,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-073649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024073649/ownership.xml","form_type":"4"}},{"id":1500144,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-28T21:30:19.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":1154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of May 23, 2025 or the date of the 2025 annual meeting of the stockholders of the Issuer, subject to continued service."}],"balance_after":1154,"derivative":{"exercise_price":137.53,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":1154},"source":{"system":"sec-edgar","filing":"0000950170-24-065398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024065398/ownership.xml","form_type":"4"}},{"id":1500143,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-28T21:30:19.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 732 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1925,"source":{"system":"sec-edgar","filing":"0000950170-24-065398","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024065398/ownership.xml","form_type":"4"}},{"id":1524517,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-07T20:30:12.000Z","date":"2024-05-03","kind":"sale","planned":true,"acquired":false,"shares":6895,"price":125.26,"value":863667.7,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $125.00 to $125.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":193146,"source":{"system":"sec-edgar","filing":"0000950170-24-054600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024054600/ownership.xml","form_type":"4"}},{"id":1524516,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-07T20:30:12.000Z","date":"2024-05-03","kind":"sale","planned":true,"acquired":false,"shares":5130,"price":124.76,"value":640018.8,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $124.75 to $124.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":200041,"source":{"system":"sec-edgar","filing":"0000950170-24-054600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024054600/ownership.xml","form_type":"4"}},{"id":1527737,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-03T20:32:05.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":110,"value":220000.0,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023."}],"balance_after":205171,"source":{"system":"sec-edgar","filing":"0000950170-24-052972","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024052972/ownership.xml","form_type":"4"}},{"id":1527736,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-03T20:32:05.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":108.47,"value":10847.0,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023."}],"balance_after":207171,"source":{"system":"sec-edgar","filing":"0000950170-24-052972","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024052972/ownership.xml","form_type":"4"}},{"id":1527735,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-03T20:32:05.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":1704,"price":106.89,"value":182140.56,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.58 to $107.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":207271,"source":{"system":"sec-edgar","filing":"0000950170-24-052972","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024052972/ownership.xml","form_type":"4"}},{"id":1527734,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-03T20:32:05.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":11236,"price":105.7,"value":1187645.2,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $105.50 to $106.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":208975,"source":{"system":"sec-edgar","filing":"0000950170-24-052972","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024052972/ownership.xml","form_type":"4"}},{"id":1594971,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-05T23:16:08.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":300,"price":85.48,"value":25644.0,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $85.39 to $85.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":220211,"source":{"system":"sec-edgar","filing":"0000950170-24-026472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024026472/ownership.xml","form_type":"4"}},{"id":1594970,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-05T23:16:08.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":2900,"price":84.74,"value":245746.0,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $84.28 to $85.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":220511,"source":{"system":"sec-edgar","filing":"0000950170-24-026472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024026472/ownership.xml","form_type":"4"}},{"id":1594969,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-05T23:16:08.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":5746,"price":83.63,"value":480537.98,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $83.26 to $84.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":223411,"source":{"system":"sec-edgar","filing":"0000950170-24-026472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024026472/ownership.xml","form_type":"4"}},{"id":1594968,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-05T23:16:08.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":4234,"price":82.84,"value":350744.56,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.25 to $83.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":229157,"source":{"system":"sec-edgar","filing":"0000950170-24-026472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024026472/ownership.xml","form_type":"4"}},{"id":1594967,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-05T23:16:08.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":200,"price":81.41,"value":16282.0,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023."}],"balance_after":233391,"source":{"system":"sec-edgar","filing":"0000950170-24-026472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017024026472/ownership.xml","form_type":"4"}},{"id":1666391,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2024-01-30T21:53:20.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 26, 2024, and will vest on January 1, 2025."}],"balance_after":15000,"derivative":{"exercise_price":53.75,"expiration_date":"2034-01-26","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-008924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024008924/ownership.xml","form_type":"4"}},{"id":1727491,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-29T21:38:08.000Z","date":"2023-11-28","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":70.14,"value":701400.0,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"balance_after":233591,"source":{"system":"sec-edgar","filing":"0000950170-23-066771","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017023066771/ownership.xml","form_type":"4"}},{"id":1835499,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-07-06T01:53:11.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable on June 30, 2024, subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":4.11,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-23-031873","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017023031873/ownership.xml","form_type":"4"}},{"id":1874483,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-30T20:32:15.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":1916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of May 25, 2024 or the date of the 2024 annual meeting of the stockholders of the Issuer, subject to continued service."}],"balance_after":1916,"derivative":{"exercise_price":71.33,"expiration_date":"2023-05-25","underlying":"Common Stock","underlying_shares":1916},"source":{"system":"sec-edgar","filing":"0000950170-23-024887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017023024887/ownership.xml","form_type":"4"}},{"id":1874482,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T20:32:15.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":1193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 1,193 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1193,"source":{"system":"sec-edgar","filing":"0000950170-23-024887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000095017023024887/ownership.xml","form_type":"4"}},{"id":1989933,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-28T01:00:36.000Z","date":"2023-02-23","kind":"sale","acquired":false,"shares":10000,"price":75.13,"value":751300.0,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $75.00 to $75.59, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":243591,"source":{"system":"sec-edgar","filing":"0000899243-23-006281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924323006281/doc4.xml","form_type":"4"}},{"id":1989957,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2023-02-27T22:01:49.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":15000,"derivative":{"exercise_price":75.18,"expiration_date":"2033-01-26","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-013249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919123013249/doc4.xml","form_type":"4"}},{"id":2198928,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T00:30:30.000Z","date":"2022-07-29","kind":"sale","acquired":false,"shares":48515,"price":39.98,"value":1939629.7,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $39.90 to $40.10, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":253591,"source":{"system":"sec-edgar","filing":"0000899243-22-027253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924322027253/doc4.xml","form_type":"4"}},{"id":2211557,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T22:17:38.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":48515,"price":35,"value":1698025.0,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $34.90 to $35.12, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":302106,"source":{"system":"sec-edgar","filing":"0000899243-22-025482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924322025482/doc4.xml","form_type":"4"}},{"id":2241588,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-06T20:28:41.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant, June 1, 2023, or the date of the following annual meeting of shareholders of the Company."}],"balance_after":13500,"derivative":{"exercise_price":28.12,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0000899243-22-021194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924322021194/doc4.xml","form_type":"4"}},{"id":2279127,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-06T20:05:50.000Z","date":"2022-05-04","kind":"sale","acquired":false,"shares":48516,"price":29.94,"value":1452569.04,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $29.90 to $30.07, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":350621,"source":{"system":"sec-edgar","filing":"0000899243-22-017085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924322017085/doc4.xml","form_type":"4"}},{"id":2326850,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2022-03-17T20:45:05.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":3542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on January 22, 2020 and are fully vested."}],"balance_after":21458,"derivative":{"exercise_price":53.27,"expiration_date":"2030-01-22","underlying":"Class A Common Stock","underlying_shares":3542},"source":{"system":"sec-edgar","filing":"0001209191-22-019620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122019620/doc4.xml","form_type":"4"}},{"id":2326849,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2022-03-17T20:45:05.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":5308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on January 22, 2019 and are fully vested."}],"balance_after":5208,"derivative":{"exercise_price":43.58,"expiration_date":"2029-01-22","underlying":"Class A Common Stock","underlying_shares":5308},"source":{"system":"sec-edgar","filing":"0001209191-22-019620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122019620/doc4.xml","form_type":"4"}},{"id":2326848,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-17T20:45:05.000Z","date":"2022-03-15","kind":"sale","acquired":false,"shares":8850,"price":65.471,"value":579418.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.09 to $66.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-019620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122019620/doc4.xml","form_type":"4"}},{"id":2326847,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-17T20:45:05.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":3542,"price":53.27,"value":188682.34,"ownership":{"direct":true},"balance_after":8850,"source":{"system":"sec-edgar","filing":"0001209191-22-019620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122019620/doc4.xml","form_type":"4"}},{"id":2326846,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-17T20:45:05.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":5308,"price":43.58,"value":231322.64,"ownership":{"direct":true},"balance_after":5308,"source":{"system":"sec-edgar","filing":"0001209191-22-019620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122019620/doc4.xml","form_type":"4"}},{"id":2339579,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2022-03-11T01:07:29.000Z","date":"2022-03-10","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on January 22, 2019 and are fully vested."}],"balance_after":10516,"derivative":{"exercise_price":43.58,"expiration_date":"2029-01-22","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-018065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122018065/doc4.xml","form_type":"4"}},{"id":2339578,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2022-03-11T01:07:29.000Z","date":"2022-03-08","kind":"exercise","acquired":false,"shares":4484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on January 22, 2019 and are fully vested."}],"balance_after":20516,"derivative":{"exercise_price":43.58,"expiration_date":"2029-01-22","underlying":"Class A Common Stock","underlying_shares":4484},"source":{"system":"sec-edgar","filing":"0001209191-22-018065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122018065/doc4.xml","form_type":"4"}},{"id":2339577,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-11T01:07:29.000Z","date":"2022-03-10","kind":"sale","acquired":false,"shares":10000,"price":70.0398,"value":700398.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.135, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-018065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122018065/doc4.xml","form_type":"4"}},{"id":2339576,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-11T01:07:29.000Z","date":"2022-03-10","kind":"exercise","acquired":true,"shares":10000,"price":43.58,"value":435800.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-22-018065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122018065/doc4.xml","form_type":"4"}},{"id":2339575,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-11T01:07:29.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":4484,"price":72,"value":322848.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-018065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122018065/doc4.xml","form_type":"4"}},{"id":2339574,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-11T01:07:29.000Z","date":"2022-03-08","kind":"exercise","acquired":true,"shares":4484,"price":43.58,"value":195412.72,"ownership":{"direct":true},"balance_after":4484,"source":{"system":"sec-edgar","filing":"0001209191-22-018065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122018065/doc4.xml","form_type":"4"}},{"id":2344063,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-03-08T21:26:49.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable in 36 substantially equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following March 4, 2022."}],"balance_after":14500,"derivative":{"exercise_price":4.77,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0000899243-22-009917","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924322009917/doc4.xml","form_type":"4"}},{"id":2420968,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2022-01-31T22:01:06.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on\nJanuary 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly\nbasis over the following 36 months."}],"balance_after":15000,"derivative":{"exercise_price":63.68,"expiration_date":"2032-01-27","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-005619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919122005619/doc4.xml","form_type":"4"}},{"id":2469629,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T22:18:04.000Z","date":"2021-12-15","kind":"gift","acquired":false,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"balance_after":399137,"source":{"system":"sec-edgar","filing":"0000899243-21-048617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924321048617/doc4.xml","form_type":"4"}},{"id":2688689,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-01T21:21:26.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant, May 27, 2022, or the date of the following annual meeting of shareholders of the Company."}],"balance_after":13500,"derivative":{"exercise_price":26.26,"expiration_date":"2031-05-27","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0000899243-21-021348","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924321021348/doc4.xml","form_type":"4"}},{"id":2716096,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2021-05-12T20:38:10.000Z","date":"2021-05-10","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":43.77,"expiration_date":"2028-01-22","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-032071","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919121032071/doc4.xml","form_type":"4"}},{"id":2716095,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-12T20:38:10.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":25000,"price":71.96,"value":1799000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.80 to $72.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-032071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919121032071/doc4.xml","form_type":"4"}},{"id":2716094,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-12T20:38:10.000Z","date":"2021-05-10","kind":"exercise","acquired":true,"shares":25000,"price":43.77,"value":1094250.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-21-032071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919121032071/doc4.xml","form_type":"4"}},{"id":2791517,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:26.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":9494,"price":9.04,"value":85825.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":12.96,"expiration_date":"2030-06-24","underlying":"Ordinary Shares","underlying_shares":9494},"source":{"system":"sec-edgar","filing":"0001140361-21-008338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000114036121008338/form4.xml","form_type":"4"}},{"id":2791516,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:26.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":7.83,"value":58388.31,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":14.17,"expiration_date":"2025-06-09","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000114036121008338/form4.xml","form_type":"4"}},{"id":2791515,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:26.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":8.98,"value":66963.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":13.02,"expiration_date":"2024-12-01","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000114036121008338/form4.xml","form_type":"4"}},{"id":2791514,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:26.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":14914,"price":8.98,"value":133927.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":13.02,"expiration_date":"2024-12-01","underlying":"Ordinary Shares","underlying_shares":14914},"source":{"system":"sec-edgar","filing":"0001140361-21-008338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000114036121008338/form4.xml","form_type":"4"}},{"id":2791513,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:26.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":7.56,"value":56374.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":14.44,"expiration_date":"2029-06-18","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000114036121008338/form4.xml","form_type":"4"}},{"id":2791512,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:26.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":7.51,"value":56002.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":14.49,"expiration_date":"2028-06-19","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000114036121008338/form4.xml","form_type":"4"}},{"id":2791511,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:26.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":7.54,"value":56225.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":14.46,"expiration_date":"2027-06-06","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000114036121008338/form4.xml","form_type":"4"}},{"id":2791510,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:26.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":13.35,"value":99550.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":8.65,"expiration_date":"2026-06-28","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008338","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000114036121008338/form4.xml","form_type":"4"}},{"id":2791509,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-03-12T21:35:26.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":4081,"price":22,"value":89782.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the \"Scheme\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-21-008338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000114036121008338/form4.xml","form_type":"4"}},{"id":2868795,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-10T23:59:00.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":200,"price":34.18,"value":6836.0,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":424637,"source":{"system":"sec-edgar","filing":"0000899243-21-005746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924321005746/doc4.xml","form_type":"4"}},{"id":2868794,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-10T23:59:00.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":9968,"price":32.8,"value":326950.4,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.50 to $33.30 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":424837,"source":{"system":"sec-edgar","filing":"0000899243-21-005746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924321005746/doc4.xml","form_type":"4"}},{"id":2904091,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2021-01-19T21:55:06.000Z","date":"2021-01-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":15000,"derivative":{"exercise_price":65.05,"expiration_date":"2031-01-14","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-004039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919121004039/doc4.xml","form_type":"4"}},{"id":3038932,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2020-09-03T20:46:22.000Z","date":"2020-09-02","kind":"exercise","acquired":false,"shares":5600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on January 30, 2017 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":26.27,"expiration_date":"2027-01-30","underlying":"Class A Common Stock","underlying_shares":5600},"source":{"system":"sec-edgar","filing":"0001209191-20-049429","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919120049429/doc4.xml","form_type":"4"}},{"id":3038931,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-09-03T20:46:22.000Z","date":"2020-09-02","kind":"sale","acquired":false,"shares":5600,"price":56.85,"value":318360.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.85 to $56.88, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-049429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919120049429/doc4.xml","form_type":"4"}},{"id":3038930,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-09-03T20:46:22.000Z","date":"2020-09-02","kind":"exercise","acquired":true,"shares":5600,"price":26.27,"value":147112.0,"ownership":{"direct":true},"balance_after":5600,"source":{"system":"sec-edgar","filing":"0001209191-20-049429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919120049429/doc4.xml","form_type":"4"}},{"id":3046165,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2020-08-26T20:30:47.000Z","date":"2020-08-25","kind":"exercise","acquired":false,"shares":17400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on January 30, 2017 and are fully vested."}],"balance_after":5600,"derivative":{"exercise_price":26.27,"expiration_date":"2027-01-30","underlying":"Class A Common Stock","underlying_shares":17400},"source":{"system":"sec-edgar","filing":"0001209191-20-048394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919120048394/doc4.xml","form_type":"4"}},{"id":3046164,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-08-26T20:30:47.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":17400,"price":54.4,"value":946560.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.25 to $54.65, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-048394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919120048394/doc4.xml","form_type":"4"}},{"id":3046163,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-08-26T20:30:47.000Z","date":"2020-08-25","kind":"exercise","acquired":true,"shares":17400,"price":26.27,"value":457098.0,"ownership":{"direct":true},"balance_after":17400,"source":{"system":"sec-edgar","filing":"0001209191-20-048394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919120048394/doc4.xml","form_type":"4"}},{"id":3098344,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"Share Option (Right to Buy)","published_at":"2020-06-26T20:03:26.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":9494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options granted under Issuer's 2013 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option will vest and become exercisable as to 100% of the underlying shares on the earlier of the first anniversary of the date of grant or the date of the first annual general meeting of the shareholders held after the date of grant."}],"balance_after":9494,"derivative":{"exercise_price":12.96,"expiration_date":"2030-06-24","underlying":"Ordinary Shares","underlying_shares":9494},"source":{"system":"sec-edgar","filing":"0001437749-20-013980","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000143774920013980/rdgdoc.xml","form_type":"4"}},{"id":3098343,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2020-06-26T20:03:26.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":4081,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4081,"source":{"system":"sec-edgar","filing":"0001437749-20-013980","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000143774920013980/rdgdoc.xml","form_type":"4"}},{"id":3120085,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T20:28:48.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":15934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant, June 4, 2021, or the date of the following annual meeting of shareholders of the Company."}],"balance_after":15934,"derivative":{"exercise_price":14.2,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":15934},"source":{"system":"sec-edgar","filing":"0000899243-20-015443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924320015443/doc4.xml","form_type":"4"}},{"id":3302908,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2020-01-24T21:47:56.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":25000,"derivative":{"exercise_price":53.27,"expiration_date":"2030-01-22","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-004866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919120004866/doc4.xml","form_type":"4"}},{"id":3384531,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-31T20:52:35.000Z","date":"2019-10-29","kind":"disposition_to_issuer","acquired":false,"shares":106112,"price":4.28,"value":454159.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation (\"Parent\"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent (\"Merger Sub\"), dated as of August 7, 2019 (the \"Merger Agreement\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares represent 85,375 shares of the Issuer's common stock and 20,737 restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger (the \"Effective Time\"), which occurred on October 29, 2019, (i) each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $4.28 in cash, without interest and less any applicable withholding taxes, and (ii) each outstanding RSU converted into the right to receive a cash payment equal to the product of (a) $4.28 and (b) the number of shares of the Issuer's common stock underlying the RSU as of the Effective Time, without interest and net of any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001387131-19-008135","document":"tobin-form4_102919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000138713119008135/tobin-form4_102919.xml","form_type":"4"}},{"id":3395148,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-09T21:31:04.000Z","date":"2019-10-07","kind":"grant","acquired":true,"shares":1170,"price":4.27,"value":4995.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. (\"Corindus\") Director Compensation Policy in lieu of the reporting person's quarterly board retainer of $5,000."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 27,649 shares of common stock related to RSUs granted as part of the director's 2019 annual equity award which provided for vesting in quarterly installments on August 3, 2019, November 3, 2019, February 3, 2020 and May 3, 2020, subject to the reporting person's continuous service with Corindus through each such vesting date."}],"balance_after":106112,"source":{"system":"sec-edgar","filing":"0001387131-19-007521","document":"tobin-form4_100719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000138713119007521/tobin-form4_100719.xml","form_type":"4"}},{"id":3464134,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-10T22:08:01.000Z","date":"2019-07-08","kind":"grant","acquired":true,"shares":1453,"price":3.44,"value":4998.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. (\"Corindus\") Director Compensation Policy in lieu of the reporting person's quarterly board retainer of $5,000."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 27,649 shares of common stock related to RSUs granted as part of the director's 2019 annual equity award which provided for vesting in quarterly installments on August 3, 2019, November 3, 2019, February 3, 2020 and May 3, 2020, subject to the reporting person's continuous service with Corindus through each such vesting date."}],"balance_after":104942,"source":{"system":"sec-edgar","filing":"0001387131-19-004969","document":"tobin-form4_070819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000138713119004969/tobin-form4_070819.xml","form_type":"4"}},{"id":3483862,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true}}],"security":"SHARE OPTION (RIGHT TO BUY)","published_at":"2019-06-19T20:31:07.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":7457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant."}],"balance_after":7457,"derivative":{"exercise_price":14.44,"expiration_date":"2029-06-18","underlying":"ORDINARY SHARES","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001437749-19-012288","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000143774919012288/rdgdoc.xml","form_type":"4"}},{"id":3536337,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-07T22:35:12.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":27649,"price":2.17,"value":59998.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock represents shares issuable upon vesting of restricted stock units (RSUs) granted as part of the director's 2019 annual equity award. The RSUs provide for vesting in quarterly installments on August 3, 2019, November 3, 2019, February 3, 2020 and May 3, 2020, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. (Corindus) through each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 53,326 shares of common stock related to RSUs granted as part of the director's 2018 annual equity award which provided for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date."}],"balance_after":103489,"source":{"system":"sec-edgar","filing":"0001387131-19-003400","document":"tobin-form4_050319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000138713119003400/tobin-form4_050319.xml","form_type":"4"}},{"id":3537834,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2019-05-06T22:45:20.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":221820,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":63377},"source":{"system":"sec-edgar","filing":"0000899243-19-012294","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924319012294/doc4.xml","form_type":"4"}},{"id":3537833,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-05-06T22:45:20.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":400000,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":114285},"source":{"system":"sec-edgar","filing":"0000899243-19-012294","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924319012294/doc4.xml","form_type":"4"}},{"id":3537832,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-05-06T22:45:20.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":400000,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":114286},"source":{"system":"sec-edgar","filing":"0000899243-19-012294","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924319012294/doc4.xml","form_type":"4"}},{"id":3537831,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-06T22:45:20.000Z","date":"2019-05-06","kind":"exercise","acquired":true,"shares":291948,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Preferred Stock reported herein is preferred stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the\nMerger Agreement, such preferred stock of TransMedics, Inc. was converted into shares of common stock of the Issuer based on (i) the one-for-one ratio on which such shares of\npreferred stock of TransMedics Inc. were convertible into shares of common stock of TransMedics Inc. according to their terms and (ii) the 3.5-for-one ratio on which shares of\ncommon stock of TransMedics, Inc. were converted into shares of common stock of the Issuer. The Preferred Stock has no expiration date."}],"balance_after":434805,"source":{"system":"sec-edgar","filing":"0000899243-19-012294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924319012294/doc4.xml","form_type":"4"}},{"id":3537830,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-06T22:45:20.000Z","date":"2019-05-06","kind":"other","acquired":true,"shares":142857,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to\nthe terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\") such\ncommon stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to\nthe terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\") such\ncommon stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."}],"balance_after":142857,"source":{"system":"sec-edgar","filing":"0000899243-19-012294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924319012294/doc4.xml","form_type":"4"}},{"id":3537829,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-06T22:45:20.000Z","date":"2019-05-06","kind":"other","acquired":false,"shares":500000,"ownership":{"direct":false,"nature":"By the James R. Tobin 2012 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to\nthe terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\") such\ncommon stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to\nthe terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\") such\ncommon stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-012294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000089924319012294/doc4.xml","form_type":"4"}},{"id":3559202,"issuer":{"id":154132,"kind":"organization","name":"Corindus Vascular Robotics, Inc.","symbol":"CVRS"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-09T22:15:39.000Z","date":"2019-04-05","kind":"grant","acquired":true,"shares":2358,"price":2.12,"value":4998.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. (\"Corindus\") Director Compensation Policy in lieu of the reporting person's quarterly retainer of $5,000."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 53,326 shares of common stock related to restricted stock units (\"RSUs\") granted as part of the director's 2018 annual equity award.  The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date."}],"balance_after":75840,"source":{"system":"sec-edgar","filing":"0001387131-19-002574","document":"tobin-form4_040519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190128/000138713119002574/tobin-form4_040519.xml","form_type":"4"}},{"id":3625948,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2019-02-28T22:27:43.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest over a three-year period with one-twelfth (1/12) of the options granted vesting on March 31, 2017, and the balance of the options granted vesting ratably on a quarterly basis over the following 11 quarters."}],"balance_after":23000,"derivative":{"exercise_price":26.27,"expiration_date":"2027-01-30","underlying":"Class A Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-19-014613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919119014613/doc4.xml","form_type":"4"}},{"id":3625947,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2019-02-28T22:27:43.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vest over a three-year period with one-twelfth (1/12) of the options granted vesting on March 31, 2016, and the balance of the options vesting ratably on a quarterly basis over the following 11 quarters."}],"balance_after":0,"derivative":{"exercise_price":25.52,"expiration_date":"2026-01-25","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-014613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919119014613/doc4.xml","form_type":"4"}},{"id":3625946,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2019-02-28T22:27:43.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":6100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on August 28, 2015, and vested over a three-year period with one-twelfth (1/12) of the options granted vesting on December 31, 2015, and the balance of the options granted vesting ratably on a quarterly basis over the following 11 quarters."}],"balance_after":0,"derivative":{"exercise_price":24.75,"expiration_date":"2025-08-28","underlying":"Class A Common Stock","underlying_shares":6100},"source":{"system":"sec-edgar","filing":"0001209191-19-014613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919119014613/doc4.xml","form_type":"4"}},{"id":3625945,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2019-02-28T22:27:43.000Z","date":"2019-02-26","kind":"exercise","acquired":false,"shares":8900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on August 28, 2015, and vested over a three-year period with one-twelfth (1/12) of the options granted vesting on December 31, 2015, and the balance of the options granted vesting ratably on a quarterly basis over the following 11 quarters."}],"balance_after":6100,"derivative":{"exercise_price":24.75,"expiration_date":"2025-08-28","underlying":"Class A Common Stock","underlying_shares":8900},"source":{"system":"sec-edgar","filing":"0001209191-19-014613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919119014613/doc4.xml","form_type":"4"}},{"id":3625944,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-02-28T22:27:43.000Z","date":"2019-02-28","kind":"sale","acquired":false,"shares":9300,"price":47.04,"value":437472.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-014613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919119014613/doc4.xml","form_type":"4"}},{"id":3625943,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-02-28T22:27:43.000Z","date":"2019-02-28","kind":"sale","acquired":false,"shares":18800,"price":48.1,"value":904280.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.33, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":9300,"source":{"system":"sec-edgar","filing":"0001209191-19-014613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919119014613/doc4.xml","form_type":"4"}},{"id":3625942,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-02-28T22:27:43.000Z","date":"2019-02-28","kind":"exercise","acquired":true,"shares":2000,"price":26.27,"value":52540.0,"ownership":{"direct":true},"balance_after":28100,"source":{"system":"sec-edgar","filing":"0001209191-19-014613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919119014613/doc4.xml","form_type":"4"}},{"id":3625941,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":22830,"kind":"person","name":"TOBIN JAMES R","position":1,"cik":"0001190128","reported_name":"TOBIN JAMES R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-02-28T22:27:43.000Z","date":"2019-02-28","kind":"exercise","acquired":true,"shares":20000,"price":25.52,"value":510400.0,"ownership":{"direct":true},"balance_after":26100,"source":{"system":"sec-edgar","filing":"0001209191-19-014613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919119014613/doc4.xml","form_type":"4"}}],"next_cursor":"2019-02-28T22:27:43.000000Z,3625941"}